Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
Clinical trial NCT00355888 · COMPLETED
Trial details
- NCT number
- NCT00355888
- Sponsor
- Mebiopharm Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2008-11-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.